Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age

por Tesser, John, Kafka, Shelly, DeHoratius, Raphael J., Xu, Stephen, Hsia, Elizabeth C., Turkiewicz, Anthony
Publicado en Arthritis Res Ther (2019)

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous...

por Ellis, Lorie A, Malangone-Monaco, Elisabetta, Varker, Helen, Stetsovsky, Diana, Kubacki, Maureen, DeHoratius, Raphael J, Kafka, Shelly
Publicado en Clinicoecon Outcomes Res (2019)

Efficacy of ustekinumab in biologic-naïve patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2

por McInnes, Iain B, Chakravarty, Soumya D, Apaolaza, Isabel, Kafka, Shelly, Hsia, Elizabeth C, You, Yin, Kavanaugh, Arthur
Publicado en RMD Open (2019)

Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics

por Ritchlin, Christopher T., Stahle, Mona, Poulin, Yves, Bagel, Jerry, Chakravarty, Soumya D., Kafka, Shelly, Srivastava, Bhaskar, Langholff, Wayne, Gottlieb, Alice B.
Publicado en BMC Rheumatol (2019)

Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, r...

por Helliwell, Philip S, Gladman, Dafna D, Chakravarty, Soumya D, Kafka, Shelly, Karyekar, Chetan S, You, Yin, Campbell, Kim, Sweet, Kristen, Kavanaugh, Arthur, Gensler, Lianne S
Publicado en RMD Open (2020)

Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study...

por Mease, Philip, Elaine Husni, M., Chakravarty, Soumya D., Kafka, Shelly, Parenti, Dennis, Kim, Lilianne, Hung Lo, Kim, Hsia, Elizabeth C., Kavanaugh, Arthur
Publicado en ACR Open Rheumatol (2020)

TNF Antagonist Responsiveness in a United States Rheumatoid Arthritis Cohort

por Greenberg, Jeffrey D., Kishimoto, Mitsumasa, Strand, Vibeke, Cohen, Stanley B., Olenginski, Thomas P, Harrington, Thomas, Kafka, Shelly P., Reed, George, Kremer, Joel M.
Publicado 2008

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: res...

por Mease, Philip, Husni, M. Elaine, Kafka, Shelly, Chakravarty, Soumya D., Harrison, Diane D., Lo, Kim Hung, Xu, Stephen, Hsia, Elizabeth C., Kavanaugh, Arthur
Publicado en Arthritis Res Ther (2020)

Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry

por Kavanaugh, Arthur, Papp, Kim, Gottlieb, Alice B., de Jong, Elke M. G. J., Chakravarty, Soumya D., Kafka, Shelly, Langholff, Wayne, Farahi, Kamyar, Srivastava, Bhaskar, Scher, Jose U.
Publicado en BMC Rheumatol (2018)